Title for MeetingAbstracts
Alphabetical listing of titles
Opportunistic parasitic infections in HIV infected patients.
Opportunistic viral infections in 124 AIDS patients recognised by cell culture virus isolation.
Opportunities and Challenges in implementing evidence-base prevention and care programmes in developing countries.
Opportunities and Challenges in Improving Addiction Treatment: What Works? What's Needed?
Opportunities and Challenges to Scaling up in Ukraine: New GFATM Project on HIV prevention among vulnerable groups.
Opportunities for Early Therapy of Respiratory Syncytial Virus (RSV) Infection: What Happens Before Hospitalization.
Opportunities for help: the imperative of 'youth centre services' in adolescent sexual and reproductive health development.
Opportunities for sustainability in Bangkok's STD clinics.
Opportunities in Public Health Services Research.
Opportunities, obligations, and obstacles to discussion of advance directives: a national survey of VA physicians.
Opportunity to enhance accrual to clinical trials using a microcomputer.
Opposing effects of AZT resistance and foscarnet resistance mutations on nucleotide-dependent removal of AZTMP from blocked primer/ templates by HIV-1 reverse transcriptase suggests potential benefits of combination therapy with AZT and foscarnet.
Opposite effects of transforming growth factor-beta (TGF-beta) on HIV expression in chronically versus acutely infected monocytic cells.
Oppressed group membership and group therapy with HIV-infected, Latino injection drug users.
Opsonization of Cryptococcus neoformans by a human IgM and mAb.
Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells.
Opsonophagocytic dysfunction in HIV-infected patients.
Opt-out policy strategies for the provision of voluntary counselling and testing (VCT) in the context of Antiretrovirals (ARV) in resource constrained settings.
Opthalmologic complications of intravenous cidofovir.
Optic neuritis in syphilis.
Optimal Antibiotic Pharmacodynamics in the Treatment of Pseudomonas aeruginosa Bacteremia.
Optimal control of human immune system and HIV interaction dynamics.
Optimal d4T-therapy in HIV-1-positive patients from a neurological point of view - lower dose, less side effects, equal effectivity?
Optimal Design of Phase II Antiretroviral (ARV), Short-Term (SM) Monotherapy Clinical Trials (CT).
Optimal diabetes disease management: direct costs for capitation.
Optimal estimation of glomerular filtration rate in patients infected with human immunodeficiency virus.
Optimal HAART in pregnant women with multi-drug resistant virus.
Optimal hospital care eludes injection drug users in vancouver.
Optimal Nursing Home Staffing to Minimize Decubitus Ulcer Costs.